ESC 365 - Optimal medical treatment and outcomes in left ventricular assist device carriers: insight from the PCHF-VAD registry

HFA Premium Access

Optimal medical treatment and outcomes in left ventricular assist device carriers: insight from the PCHF-VAD registry

Session: Heart Failure ePosters - focus on Chronic Heart Failure 5

Topic: Ventricular Assist Devices

Speaker: Doctor N. Jakus (Zagreb, HR)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Doctor Nina Jakus

University Hospital Centre Zagreb, Zagreb (Croatia)

0 follower

32 more presentations in this session

Comparison 8 vs. 10mm fenestration size of the atrial flow regulator in patients with heart failure with reduced and preserved ejection fraction: an analysis of the Prelieve Trial

Speaker: Doctor C. Paitazoglou (Luebeck, DE)

HDAC6 inhibition reduces cardiac fibrosis, enhances mitochondrial function and demonstrates comparable efficacy as empagliflozin in a mouse model of heart failure with preserved ejection fraction

Speaker: Mr J. Yang (South San Francisco, US)

Improved vascular function after ventricular assist device implantation

Speaker: Doctor D. Nebunu (Zurich, CH)

Left-heart reverse remodeling patterns following treatment with sacubitril/valsartan

Speaker: Doctor A. Abboud (Boston, US)

Identifying distinct clinical subgroups in heart failure with mildly reduced ejection fraction

Speaker: Assistant Professor A. Uijl (Amsterdam, NL)

Access the full session

Heart Failure ePosters - focus on Chronic Heart Failure 5

Speakers: Doctor N. Jakus, Doctor C. Paitazoglou, Mr J. Yang, Doctor D. Nebunu, Doctor A. Abboud...

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources